• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[弥漫性毒性甲状腺肿和甲状腺功能正常的甲状腺肿中止血的甲状腺组织联系]

[Thyroid tissue link of hemostasis in diffuse toxic and euthyroid goiter].

作者信息

Kirichuk V F

出版信息

Probl Endokrinol (Mosk). 1979 May-Jun;25(3):27-31.

PMID:582337
Abstract

Blood coagulation system and fibrinolysis factors contained in the thyroid gland tissue of patients with diffuse toxic and euthyroid goiter and also of apparently healthy persons were investigated. The thyroid gland of healthy persons was shown to possess thromboplastin, antithrombin, anticoagulant, antiheparin, and fibrinolytic properties and to contain plasminogen, plasminogen activators, antiplasmins. The function of the external hemocoagulation system was reduced due to diminished thromboplastin and antiheparin activity of the gland tissue, reduction of aggregation and increase of disaggregation properties of the gland tissue. External blood coagulation system was undisturbed in patients with euthyroid gland. Local fibrinolysis was enhanced in patients with diffuse toxic goiter on account of increase in the thyroid gland of plasminogen activators, reduction of antiplasmin activity, and increase of the nonenzymatic fibrinolysis activity. Analogous changes in local fibrinolysis occurred in patients with euthyroid goiter.

摘要

对弥漫性毒性甲状腺肿、甲状腺功能正常的甲状腺肿患者以及明显健康人的甲状腺组织中的血液凝固系统和纤维蛋白溶解因子进行了研究。结果表明,健康人的甲状腺具有凝血活酶、抗凝血酶、抗凝剂、抗肝素和纤维蛋白溶解特性,并含有纤溶酶原、纤溶酶原激活剂和抗纤溶酶。由于甲状腺组织中凝血活酶和抗肝素活性降低、甲状腺组织聚集性降低和分散性增加,导致外源性血液凝固系统功能降低。甲状腺功能正常的患者外源性血液凝固系统未受干扰。弥漫性毒性甲状腺肿患者由于甲状腺中纤溶酶原激活剂增加、抗纤溶酶活性降低和非酶促纤维蛋白溶解活性增加,局部纤维蛋白溶解增强。甲状腺功能正常的甲状腺肿患者也发生了局部纤维蛋白溶解的类似变化。

相似文献

1
[Thyroid tissue link of hemostasis in diffuse toxic and euthyroid goiter].[弥漫性毒性甲状腺肿和甲状腺功能正常的甲状腺肿中止血的甲状腺组织联系]
Probl Endokrinol (Mosk). 1979 May-Jun;25(3):27-31.
2
[Fibrinolytic activity of blood and thyroid tissue in nodular goiter and thyrotoxicosis].[结节性甲状腺肿和甲状腺毒症患者血液及甲状腺组织的纤溶活性]
Vrach Delo. 1981 Oct(10):81-2.
3
Iodinating activity of thyroid tissue in toxic diffuse goiter.毒性弥漫性甲状腺肿中甲状腺组织的碘化活性。
J Clin Invest. 1977 Apr;59(4):723-9. doi: 10.1172/JCI108691.
4
[Fibrinogen degradation products, soluble fibrin and antithrombin III in toxic goiter patients].[毒性甲状腺肿患者的纤维蛋白原降解产物、可溶性纤维蛋白和抗凝血酶III]
Probl Endokrinol (Mosk). 1979 Jan-Feb;25(1):11-5.
5
T3-release from autonomously functioning thyroid nodules in vitro.体外自主功能性甲状腺结节的T3释放
Exp Clin Endocrinol Diabetes. 1998;106(6):489-93. doi: 10.1055/s-0029-1212022.
6
A comparison of plasma TSH levels in patients with diffuse and nodular non-toxic goiter.弥漫性和结节性非毒性甲状腺肿患者血浆促甲状腺激素水平的比较。
J Clin Endocrinol Metab. 1976 May;42(5):973-6. doi: 10.1210/jcem-42-5-973.
7
[Collagen content of the thyroid tissue and/urinary hydroxyproline in various forms of goiter].[各种类型甲状腺肿中甲状腺组织的胶原蛋白含量及/尿羟脯氨酸]
Probl Endokrinol (Mosk). 1981 Sep-Oct;27(5):20-4.
8
[Role of blood coagulating and fibrinolytic compounds from thyroid tissue in the pathogenesis of increased hemorrhagic diathesis during operations for euthyroid and thyrotoxic goiter].
Klin Khir (1962). 1979 Dec(12):38.
9
[Several kinin system indices in diseases of the thyroid gland].[甲状腺疾病中的几种激肽系统指标]
Vopr Med Khim. 1978 Nov-Dec;24(6):781-6.
10
Activity of coagulation and fibrinolytic system components in the vein thrombus.静脉血栓中凝血和纤溶系统成分的活性
Adv Med Sci. 2006;51:205-7.